{"url":"https://newsforagent.com/news/2026-11-05/amble-health-compounded-peptides-launch","markdown_url":"https://newsforagent.com/news/2026-11-05/amble-health-compounded-peptides-launch.md","title":"Amble Health Adds Six Compounded Peptides Online","headline":"Amble Health Opens Online Access to Six Compounded Peptides Under HHS Policy","description":"Amble Health now offers six compounded peptides through online medical review, with prescriptions filled by state-licensed 503A pharmacies under a new HHS interim policy.","section":"Product Launches","published_at":"2026-11-05T20:54:05+00:00","modified_at":"2026-11-05T20:54:05+00:00","author":"News Desk","key_takeaways":["Amble Health added BPC-157, TB-500, MOTS-c, Epitalon, Semax and KPV to its online medical care platform.","Patients complete an online assessment and consult a licensed provider before any prescription is written.","Medications are compounded by state-licensed 503A pharmacies under an HHS interim policy that is not FDA approval."],"companies":[{"name":"Amble Health","is_primary":true,"profile_url":"https://akta.pro/company-profiles/00ymn6n/amble-health","website":"https://joinamble.com"}],"source":{"publisher":"PR Newswire","title":"Amble Health Launches Six Compounded Peptide Options Through Online Medical Care","url":"https://www.prnewswire.com/news-releases/amble-health-launches-six-compounded-peptide-options-through-online-medical-care-302931314.html"},"other_sources":[],"tags":["Product Launches","Amble Health"],"body_markdown":"Amble Health announced on November 5, 2026 that patients can now seek prescriptions for six compounded peptides through its online medical care platform, following a new interim policy from the U.S. Department of Health and Human Services. The [PR Newswire](https://www.prnewswire.com/news-releases/amble-health-launches-six-compounded-peptide-options-through-online-medical-care-302931314.html) release names the options as BPC-157, TB-500, MOTS-c, Epitalon, Semax and KPV.\n\n## How the Amble Health Peptide Program Works\n\nPatients begin with an online health assessment and consult a licensed healthcare provider, who reviews medical history, discusses health goals and decides whether treatment is appropriate. When a prescription is written, a state-licensed 503A compounding pharmacy prepares the medication and ships it directly to the patient with instructions and ongoing support.\n\n[Amble Health](https://akta.pro/company-profiles/00ymn6n/amble-health) said the program is a prescription-based pathway, in contrast to online vendors that sell unverified peptides labeled for research use only without a prescription. Under the HHS interim policy, participating 503A pharmacies operate under state oversight and federal requirements, with ingredient manufacturers registered with the FDA and every ingredient batch backed by a Certificate of Analysis verifying identity, strength, purity and the absence of harmful contaminants.\n\n\"For patients exploring peptide therapy, knowing where a medication comes from and having clinician guidance are essential,\" said Joey Stiver, CEO of Amble Health. \"Our platform replaces guesswork with a structured pathway, connecting patients to licensed providers and state-regulated pharmacies that meet strict ingredient and testing standards.\"\n\nThe company said the HHS interim policy does not constitute FDA approval, that compounded medications are not reviewed by the FDA for safety, effectiveness or quality before marketing, and that clinical research in humans remains limited. Amble Health directs anyone considering peptide therapy to consult a physician. Patients can start an online medical review at [joinamble.com](https://joinamble.com).\n\n## Amble Health's Prior Launches and Reach\n\nAccording to akta.pro [company records](https://akta.pro/company-data), Amble Health launched the Amble Cares Program in May 2026, offering eligible low-income Americans GLP-1 weight-loss treatments at up to 50% lower cost through a direct-pay model, with eligibility set by an unnamed independent third-party financial verification partner. The same records list Bask Health, Inc. as the primary pharmacy network provider for Amble's prescription fulfillment services and show availability in all 50 states with exclusions, including video or audio visit requirements in New Mexico, Kansas, West Virginia, Louisiana and Mississippi.\n\n## Earlier Amble Health Announcements\n\nIn August 2026, Amble Health launched Med Kits, eight scenario-specific prescription medical kits for households, travelers and outdoor enthusiasts, priced from $285 to $945 and including items such as epinephrine auto-injectors and radiation emergency supplies, PR Newswire reported. That month, ValiantCEO published an interview in which Stiver discussed his bootstrapped healthcare, telehealth and wellness companies, which he said have generated over $1 billion in combined revenue.\n","publisher":{"name":"News for Agent","url":"https://newsforagent.com"}}